Unknown

Dataset Information

0

Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1.


ABSTRACT: We describe the use of iterative in situ click chemistry to design an Akt-specific branched peptide triligand that is a drop-in replacement for monoclonal antibodies in multiple biochemical assays. Each peptide module in the branched structure makes unique contributions to affinity and/or specificity resulting in a 200 nM affinity ligand that efficiently immunoprecipitates Akt from cancer cell lysates and labels Akt in fixed cells. Our use of a small molecule to preinhibit Akt prior to screening resulted in low micromolar inhibitory potency and an allosteric mode of inhibition, which is evidenced through a series of competitive enzyme kinetic assays. To demonstrate the efficiency and selectivity of the protein-templated in situ click reaction, we developed a novel QPCR-based methodology that enabled a quantitative assessment of its yield. These results point to the potential for iterative in situ click chemistry to generate potent, synthetically accessible antibody replacements with novel inhibitory properties.

SUBMITTER: Millward SW 

PROVIDER: S-EPMC3651860 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1.

Millward Steven W SW   Henning Ryan K RK   Kwong Gabriel A GA   Pitram Suresh S   Agnew Heather D HD   Deyle Kaycie M KM   Nag Arundhati A   Hein Jason J   Lee Su Seong SS   Lim Jaehong J   Pfeilsticker Jessica A JA   Sharpless K Barry KB   Heath James R JR  

Journal of the American Chemical Society 20111024 45


We describe the use of iterative in situ click chemistry to design an Akt-specific branched peptide triligand that is a drop-in replacement for monoclonal antibodies in multiple biochemical assays. Each peptide module in the branched structure makes unique contributions to affinity and/or specificity resulting in a 200 nM affinity ligand that efficiently immunoprecipitates Akt from cancer cell lysates and labels Akt in fixed cells. Our use of a small molecule to preinhibit Akt prior to screening  ...[more]

Similar Datasets

| S-EPMC3716464 | biostudies-literature
| S-EPMC5431875 | biostudies-literature
| S-EPMC3375375 | biostudies-literature
| S-EPMC3716466 | biostudies-literature
| S-EPMC10660212 | biostudies-literature
| S-EPMC2878189 | biostudies-literature
| S-EPMC3652031 | biostudies-literature
| S-EPMC2667816 | biostudies-literature
| S-EPMC4027485 | biostudies-literature
| S-EPMC7496671 | biostudies-literature